<?xml version="1.0"?>
<?xml-stylesheet type="text/xsl" href="billres.xsl"?>
<!DOCTYPE bill PUBLIC "-//US Congress//DTDs/bill.dtd//EN" "bill.dtd">
<bill bill-stage="Introduced-in-House" dms-id="HC334C52F8BAB476F941193861ADBC712" public-private="public" key="H" bill-type="olc"><metadata xmlns:dc="http://purl.org/dc/elements/1.1/">
<dublinCore>
<dc:title>117 HR 7679 IH: To amend the Federal Food, Drug, and Cosmetic Act to reauthorize the authority to grant certain exemptions, and for other purposes.</dc:title>
<dc:publisher>U.S. House of Representatives</dc:publisher>
<dc:date>2022-05-06</dc:date>
<dc:format>text/xml</dc:format>
<dc:language>EN</dc:language>
<dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
</dublinCore>
</metadata>
<form>
<distribution-code display="yes">I</distribution-code><congress display="yes">117th CONGRESS</congress><session display="yes">2d Session</session><legis-num display="yes">H. R. 7679</legis-num><current-chamber>IN THE HOUSE OF REPRESENTATIVES</current-chamber><action display="yes"><action-date date="20220506">May 6, 2022</action-date><action-desc><sponsor name-id="F000468">Mrs. Fletcher</sponsor> (for herself and <cosponsor name-id="B001257">Mr. Bilirakis</cosponsor>) introduced the following bill; which was referred to the <committee-name committee-id="HIF00">Committee on Energy and Commerce</committee-name></action-desc></action><legis-type>A BILL</legis-type><official-title display="yes">To amend the Federal Food, Drug, and Cosmetic Act to reauthorize the authority to grant certain exemptions, and for other purposes.</official-title></form><legis-body id="H39712C021DA341A185ECA916D26AE25C" style="OLC"> 
<section id="H9A505EE376FF460F9C2A9FBB9EA42BA9" section-type="section-one"><enum>1.</enum><header>Reauthorizing the humanitarian device exemption profit incentive</header><text display-inline="no-display-inline">Section 520(m)(6)(A)(iv) of the Federal Food, Drug, and Cosmetic Act (<external-xref legal-doc="usc" parsable-cite="usc/42/360j">42 U.S.C. 360j(m)(6)(A)(iv)</external-xref>) is amended by striking <quote>2022</quote> and inserting <quote>2027</quote>.</text></section> <section id="HA03B9D88A7E84A73839D59C448FA7C75"><enum>2.</enum><header>Reauthorizing the pediatric device consortia program</header><text display-inline="no-display-inline">Section 305(e) of the Food and Drug Administration Amendments Act of 2007 (<external-xref legal-doc="usc" parsable-cite="usc/42/282">42 U.S.C. 282</external-xref> note) is amended by striking <quote>fiscal years 2018 through 2022</quote> and inserting <quote>fiscal years 2023 through 2027</quote>.</text> </section> 
</legis-body></bill>

